{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.110.12.1042",
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1042",
  "identifier": [ {
    "system": "urn:ietf:rfc:3986",
    "value": "2.16.840.1.113883.3.464.1003.110.12.1042"
  } ],
  "version": "20190315",
  "name": "HepatitisBVaccineAdministered",
  "title": "Hepatitis B Vaccine Administered",
  "status": "active",
  "experimental": false,
  "publisher": "NLM",
  "expansion": {
    "identifier": "20220505",
    "timestamp": "2022-08-16T11:47:48-06:00",
    "contains": [ {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90697",
      "display": "Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90723",
      "display": "Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90740",
      "display": "Hepatitis B vaccine (HepB), dialysis or immunosuppressed patient dosage, 3 dose schedule, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90744",
      "display": "Hepatitis B vaccine (HepB), pediatric/adolescent dosage, 3 dose schedule, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90747",
      "display": "Hepatitis B vaccine (HepB), dialysis or immunosuppressed patient dosage, 4 dose schedule, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90748",
      "display": "Hepatitis B and Haemophilus influenzae type b vaccine (Hib-HepB), for intramuscular use"
    }, {
      "system": "http://www.cms.gov/Medicare/Coding/ICD10",
      "version": "2022",
      "code": "3E0234Z",
      "display": "Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach"
    }, {
      "system": "http://terminology.hl7.org/CodeSystem/icd9cm",
      "version": "2013",
      "code": "99.55",
      "display": "Prophylactic administration of vaccine against other diseases"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2020-03",
      "code": "787438002",
      "display": "Vaccination for diphtheria, pertussis, tetanus, poliomyelitis, Hepatitis B virus and Haemophilus influenzae type b (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "16584000",
      "display": "Administration of vaccine product containing only Hepatitis B virus antigen (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "170370000",
      "display": "Administration of first dose of vaccine product containing only Hepatitis B virus antigen (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "170371001",
      "display": "Administration of second dose of vaccine product containing only Hepatitis B virus antigen (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "170372008",
      "display": "Administration of third dose of vaccine product containing only Hepatitis B virus antigen (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "170373003",
      "display": "Administration of booster dose of vaccine product containing only Hepatitis B virus antigen (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "170434002",
      "display": "Administration of first dose of vaccine product containing only Hepatitis A and Hepatitis B virus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "170435001",
      "display": "Administration of second dose of vaccine product containing only Hepatitis A and B virus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "170436000",
      "display": "Administration of third dose of vaccine product containing only Hepatitis A and Hepatitis B virus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "170437009",
      "display": "Administration of booster dose of vaccine product containing only Hepatitis A and Hepatitis B virus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "312868009",
      "display": "Administration of vaccine product containing only Hepatitis A and Hepatitis B virus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "396456003",
      "display": "Administration of vaccine product containing only acellular Bordetella pertussis and Corynebacterium diphtheriae and Hepatitis B virus and inactivated whole Human poliovirus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "572561000119108",
      "display": "Administration of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Hepatitis B virus and inactivated whole Human poliovirus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "770608009",
      "display": "Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "770616000",
      "display": "Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "770617009",
      "display": "Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "770618004",
      "display": "Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2021-09",
      "code": "786846001",
      "display": "Administration of vaccine product containing only Haemophilus influenzae type B and Hepatitis B virus antigens (procedure)"
    } ]
  }
}